Indeed, tumor-derived SAPKK1/MKK4 mutants induced centrosome amplification under genotoxic stress (only in p53-negative cells)[74], which lead to increased resistance to apoptosis, chemotherapy and radiotherapy[75]. This evidence concerns the gene TP53 and neoplasm.